摘要 |
The present invention is characterized by the use of Mas G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for study, prevention and treatment of diseases. It is further characterized by the use of Mas G-protein-coupled receptor agonist and antagonists for modulation of the apoptotic activity involving alterations in the activity of the protein kinase B/Akt. Another characteristic of the invention is the use of Mas G-protein-coupled receptor agonists and antagonists, including the Ang-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, as modulators of apoptotic activity for study, prevention and treatment of degenerative diseases of organs and systems, as an auxiliary measure for organs transplantation, treatment with embryonic, non-embryonic stem cells, re-implantation of organs and tissues and other treatments that need temporary or chronic reduction of the apoptotic activity, not limitative. The invention further claims the use of Mas G-protein-coupled receptor agonists and antagonists, including the Angiotensin-(1-7) peptide and its analogues, agonists and antagonists, either peptidic or non-peptidic, formulated with pharmaceutically and pharmacologically acceptable excipients or carriers, as modulators of the apoptotic activity.
|
申请人 |
SOUZA DOS SANTOS ROBSON AUGUSTO;VELOSO BRANT PINHEIRO SERGIO;DE FARIA E SILVA RAPHAEL;SILVA LULA IVANA;BARROS DE SOUSA FREDERICO;FREZARD FREDERIC JEAN GEORGES;DOS REIS ADELINA MARTHA;DE FRANCA LUIZ RENATO;FERREIRA ANDERSON JOSE;SINISTERRA RUBERT DARIO;CAMPAGNOLE SANTOS MARIA JOSE;DE OLIVEIRA SAMPAIO WALKYRIE N;DE CASTRO LEAL MARCELO |
发明人 |
SOUZA DOS SANTOS ROBSON AUGUSTO;VELOSO BRANT PINHEIRO SERGIO;DE FARIA E SILVA RAPHAEL;SILVA LULA IVANA;BARROS DE SOUSA FREDERICO;FREZARD FREDERIC JEAN GEORGES;DOS REIS ADELINA MARTHA;DE FRANCA LUIZ RENATO;FERREIRA ANDERSON JOSE;SINISTERRA RUBERT DARIO;CAMPAGNOLE SANTOS MARIA JOSE;DE OLIVEIRA SAMPAIO WALKYRIE NEYDE;DE CASTRO LEAL MARCELO |